Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Motor Units00:46

Motor Units

A motor unit consists of two main components: a single efferent motor neuron (i.e., a neuron that carries impulses away from the central nervous system) and all of the muscle fibers it innervates. The motor neuron may innervate multiple muscle fibers, which are single cells, but only one motor neuron innervates a single muscle fiber.
Motor Units01:13

Motor Units

The motor unit is a fundamental component of the neuromuscular system and plays a crucial role in coordinating muscle contractions. It consists of a somatic motor neuron, which connects and controls multiple skeletal muscle fibers, forming a single functional segment. The axon of the motor neuron branches out and establishes synaptic connections known as neuromuscular junctions with individual muscle fibers within the motor unit.
Motor units come in different sizes, with smaller units...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].

Journal of the neurological sciences·2026
Same author

Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20.

Journal of the neurological sciences·2026
Same author

Long COVID and cognition.

European journal of neurology·2023
Same author

Novel <i>SEPSECS</i> Pathogenic Variants Featuring Unusual Phenotype of Complex Movement Disorder With Thin Corpus Callosum: A Case Report.

Neurology. Genetics·2022
Same author

Confounding clinical presentation and different disease progression in CMT4B1.

Neuromuscular disorders : NMD·2020
Same author

Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2020

Related Experiment Video

Updated: May 8, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

Multifocal motor neuropathy.

Raquel Guimarães-Costa1, Francesco Bombelli, Jean-Marc Léger

  • 1National Referral Center for Rare Neuromuscular Diseases, Institut Hospitalo-Universitaire de Neurosciences, University Hospital Pitié-Salpêtrière, University Pierre et Marie Curie, Paris VI, Paris, France.

Current Opinion in Neurology
|September 3, 2013
PubMed
Summary

Recent advances in multifocal motor neuropathy (MMN) diagnosis include sophisticated electrophysiological techniques and improved antibody testing. Subcutaneous immunoglobulin and complement inhibitors show promise for MMN treatment.

More Related Videos

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method
08:25

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method

Published on: June 7, 2018

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Related Experiment Videos

Last Updated: May 8, 2026

Multifocal Electroretinograms
16:49

Multifocal Electroretinograms

Published on: December 4, 2011

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method
08:25

CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method

Published on: June 7, 2018

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Area of Science:

  • Neurology
  • Immunology

Background:

  • Multifocal motor neuropathy (MMN) presents diagnostic challenges due to atypical presentations.
  • Long-term treatment options beyond immunoglobulin infusions are limited.

Purpose of the Study:

  • To review recent diagnostic and therapeutic advancements in MMN.
  • To highlight new findings in MMN pathophysiology and management.

Main Methods:

  • Review of recent literature on MMN diagnosis and treatment.
  • Focus on electrophysiological techniques, immunological markers, and novel therapies.

Main Results:

  • Sophisticated electrophysiological methods (e.g., triple stimulation) and MRI aid in diagnosing conduction blocks.
  • New serological markers (e.g., anti-NS6S heparin disaccharide IgM, antiglycolipid antibodies) show improved diagnostic sensitivity.
  • Subcutaneous immunoglobulin offers an alternative to intravenous administration.
  • Complement inhibitors and anti-CD20 monoclonal antibodies are emerging therapeutic targets.

Conclusions:

  • Established MMN diagnostic criteria can be challenging in complex cases.
  • Neurophysiological and laboratory advancements improve diagnostic accuracy.
  • Further research into MMN pathophysiology is crucial for developing future targeted treatments.